This photo of Knox was taken in Bray, Ireland, in July of 2018 by Knox’s best friend, his brother Riley. Knox was cancer-free and enjoying the great outdoors – a source of constant inspiration for him.
 
Along the rocky shores of life Knox is moving forward and so shall we in the fight against Glioblastoma.

Despite being first identified in the scientific literature in the 1920s, there are only four FDA-approved drugs to treat Glioblastoma (GBM). Four in 100 years. For Glioblastoma (GBM), the five-year relative survival rate is only 7.2% and median survival is only 8 months.

These devastating statistics attest to the underfunded and under-researched nature of brain cancer treatments – particularly treatments for high-grade gliomas (HGG). 

The Knox Martin Foundation for Brain Cancer Research was created to fund the next breakthrough in brain cancer – particularly in aggressive brain cancers – giving warriors like Knox a longer life expectancy.

Get Updates.

Thanks for subscribing!